© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Evommune Launches Phase 2b Trial of Oral MRGPRX2 Antagonist, EVO756, In Adults With Atopic Dermatitis
August 27, 2025
MRGPRX2 antagonism is the only known mechanism of action designed to modulate mast cells and sensory neurons, both key drivers of lesions and itch in AD.
New Vaccine Guidance from the American College of Cardiology Focuses on Adults with Heart Disease
August 27, 2025
New ACC guidance emphasizes the critical role of vaccinations in reducing infection risks and improving outcomes for adults with cardiovascular disease.
Misinformation, Disinformation Threaten Clinician-Patient Relationship and Quality of Care
August 27, 2025
A survey by The Physicians Foundation found most US clinicians feel that faulty medical information has increased in the last 5 years and half say it has increased significantly.
AAD Atopic Dermatitis Treatment Update: A Q&A With Linda Stein Gold, MD
August 27, 2025
Discover the latest advancements in atopic dermatitis treatment, including new topical agents and biologics, enhancing care for patients with moderate to severe conditions.
Family Medicine is Where Mental Health Care Starts, With Teresa Lovins, MD
August 26, 2025
Mental health issues affect half the population at some point during a lifetime. Teresa Lovins, MD, says FPs are often the first to learn that "something is going on."
FDA Expands Evolocumab Indication to Adults at Risk for Major Cardiovascular Events Due to Uncontrolled LDL-C
August 26, 2025
The FDA removed the prior requirement for a person who is already diagnosed with a cardiovascular disease.
NeuroStim Announces Single-Day TMS Protocol With High Remission Rates in Depression
August 26, 2025
One-Day TMS condenses transcranial magnetic stimulation therapy treatment from a daily month-long process to 1 day, with rapid and durable results, NeuroStim says.
Lilly’s Oral GLP-1 Orforglipron Meets End Points in Phase 3 Obesity and Diabetes Trial
August 26, 2025
Patients taking orforglipron achieved significant weight loss, hemoglobin A1c reduction, and cardiometabolic benefits in the phase 3 ATTAIN-2 study, supporting upcoming global regulatory submissions.
What Do Individuals With Obesity Want in an "Ideal" Primary Care Visit?
August 26, 2025
People with obesity may shun basic primary care for fear of shaming, lectures, inhospitable equipment, and simple lack of respect from clinicians, authors found.
2025 AAD Atopic Dermatitis Update: Linda Stein Gold, MD, on New Topical and Biologic Therapies
August 25, 2025
Linda Stein Gold, MD, reviews AAD’s 2025 updates on new topical and biologic options for adult atopic dermatitis.